Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth

Stock Track

02/27

Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.

The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.

Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1176700835"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176700835\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176700835?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176700835","market":"hk","top_or_hot":-1,"title":"Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth","media":"Stock Track","content":"<p>Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.</p><p>The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.</p><p>Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Progyny Plummets 11.21% Intraday on Disappointing Guidance, Client Loss and Slowing Growth\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-02-27 22:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.</p><p>The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.</p><p>Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PGNY","symbol_name":"Progyny","start_time":0,"source_url":"","article_id":"1176700835","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176700835","pubTimestamp":1772203003,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.The sharp drop comes after the company issued financial guidance that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PGNY":"Progyny"},"translate_title":"个股追踪|Progyny盘中暴跌11.21%，因指引令人失望、客户流失和增长放缓","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PGNY":1},"content_text":"Progyny's (PGNY) stock plummeted 11.21% during intraday trading on Friday, following a significant decline in pre-market activity.The sharp drop comes after the company issued financial guidance that fell short of analyst expectations. Progyny's outlook for the first quarter of 2026 and its adjusted earnings per share guidance for the full year 2026 were both below market expectations, triggering negative investor sentiment.Further pressure stemmed from the company's projection of slower revenue growth for fiscal year 2026, estimated between 5.1% and 9%, which represents a deceleration from the 10% growth achieved in 2025. The first-quarter 2026 revenue growth guidance of just 2.5% was particularly disappointing to analysts. The company also confirmed the loss of a large client that did not renew its contract, and reported a 1.1% revenue decline in its pharmacy benefit services segment during the latest quarter.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}